  The computer simulation of organ-scale biomechanistic models of cancer
personalized via routinely collected clinical and imaging data enables to
obtain patient-specific predictions of tumor growth and treatment response over
the anatomy of the patient's affected organ. These patient-specific
computational forecasts have been regarded as a promising approach to
personalize the clinical management of cancer and derive optimal treatment
plans for individual patients, which constitute timely and critical needs in
clinical oncology. However, the computer simulation of the underlying
spatiotemporal models can entail a prohibitive computational cost, which
constitutes a barrier to the successful development of clinically-actionable
computational technologies for personalized tumor forecasting. To address this
issue, here we propose to utilize Dynamic-Mode Decomposition (DMD) to construct
a low-dimensional representation of cancer models and accelerate their
simulation. DMD is an unsupervised machine learning method based on the
singular value decomposition that has proven useful in many applications as
both a predictive and a diagnostic tool. We show that DMD may be applied to
Fisher-Kolmogorov models, which constitute an established formulation to
represent untreated solid tumor growth that can further accommodate other
relevant cancer phenomena. Our results show that a DMD implementation of this
model over a clinically-relevant parameter space can yield impressive
predictions, with short to medium-term errors remaining under 1% and long-term
errors remaining under 20%, despite very short training periods. We posit that
this data-driven approach has the potential to greatly reduce the computational
overhead of personalized simulations of cancer models, thereby facilitating
tumor forecasting, parameter identification, uncertainty quantification, and
treatment optimization.
